Newsroom | 39506 results

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment. The submission follows the granting of Priority Review to pimicotinib by the CDE in...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment. The submission follows the granting of Priority Review to p...

BOSTON & SYDNEY--(BUSINESS WIRE)--BERKSHIRE HATHAWAY SPECIALTY INSURANCE LAUNCHES LIFE SCIENCE, BIOTECH & PHARMACEUTICAL (LBP) MANAGEMENT LIABILITY POLICY IN AUSTRALIA...

TORONTO--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), ("Jack Nathan Health", "JNH" or the "Company") announces that it was unable to file its audited consolidated financial statements, management’s discussion and analysis (MD&A), and related CEO and CFO certifications for the fiscal year ended January 31, 2025 (collectively, the “Annual Filings”) by the required deadline of May 31, 2025. The delay was primarily due to the complexity surrounding the Asset Purchas...

SAN DIEGO & CINCINNATI--(BUSINESS WIRE)--National Resilience (“Resilience”), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today provided an update on its CDMO business strategy and financing in a letter to its customers. The full letter follows: Dear Resilience Customers, Since our founding in 2020, Resilience has focused on improving the pharmaceutical supply chain and providing manufacturers of complex, advanced medicines the ability to pr...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (“Avanzanite”), een snelgroeiend gespecialiseerd farmaceutisch bedrijf dat zich toelegt op de commerciële fase en medicijnen voor zeldzame ziekten naar patiënten in Europa brengt, kondigde vandaag een exclusieve overeenkomst aan met Agios Pharmaceuticals Inc. (Nasdaq: AGIO), een biotechbedrijf uit Boston dat zich toelegt op de ontwikkeling en commercialisering van medicijnen voor zeldzame ziekten. Deze bekendmaking is officieel geldend in d...

ÁMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. («Avanzanite»), una compañía farmacéutica especializada en fase comercial de rápido crecimiento centrada en ofrecer medicamentos para enfermedades raras a pacientes de toda Europa, ha anunciado hoy un acuerdo exclusivo con Agios Pharmaceuticals Inc. (Nasdaq: AGIO), una compañía biotecnológica con sede en Boston centrada en el desarrollo y la comercialización de medicamentos para enfermedades raras. El comunicado en el idioma original es la...

TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE: MMS), a leading employer and provider of government services, today announced the latest version of its industry-leading customer experience (CX) solution, Total Experience Management (TXM), powered by Amazon Web Services (AWS). Maximus TXM was launched in 2024 and enables agencies to implement the next generation of CX through one comprehensive solution with FedRAMP-authorized technologies. Through its strategic collaboration with AWS, Maximus lever...

CANTON, Ohio--(BUSINESS WIRE)--US Acute Care Solutions (USACS) is pleased to share its success in reducing opioid prescribing rates in emergency departments (EDs) nationwide. This achievement is the result of an audit and feedback quality improvement program, designed to limit excessive prescribing in several practice settings and health systems. The Growing Epidemic Since 1999, over one million Americans have lost their lives to a drug overdose, making it the leading cause of death among those...

CUPERTINO, Calif.--(BUSINESS WIRE)--Apple® today previewed watchOS® 26, offering a beautiful new look and even more intelligence for a more personalized experience, to support users in staying active, healthy, and connected. A new design with Liquid Glass makes features like the Smart Stack, Control Center, the Photos watch face, and in-app navigation and controls more expressive, while maintaining the instant familiarity of watchOS. Apple Intelligence™ enhances the fitness experience with Work...